Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
life sciences
national blog main
boston
crispr
editas medicine
gene editing
national top stories
san francisco blog main
san francisco top stories
biotech
crispr therapeutics
crispr-cas9
feng zhang
intellia therapeutics
agios therapeutics
allergan
base editing
branden moriarty
broad institute
cancer
cas13
clinical trials
cynthia collins
david liu
david walt
deals
diagnostics
dna
drugs
editas
editor
editr
enzyme
harvard university
illumina
jennifer doudna
jim collins
john evans
What
crispr
4
×
editing
gene
4
×
medicine
cas
editas
human
allergan
beam
bio
blessing
bosley
cancer
cells
ceo
check
clinical
create
cusp
defect
depart
diagnostic
diseases
drive
edited
editor
experimental
fears
fix
flag
founders
genetic
gotten
guardian
harvard
heats
high
humans
jump
katrine
Language
Current search:
gene
×
crispr
×
" boston blog main "
×
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M